logo

Allergan Inc. (AGN)



Trade AGN now with
  Date
  Headline
11/26/2018 7:31:35 AM Allergan Names Daphne Karydas SVP Corporate Financial Planning & Analysis And Strategy
11/20/2018 7:30:57 AM Allergan Announces FDA Acceptance Of SNDA For AVYCAZ
11/9/2018 1:50:58 PM Aegon Completes Share Buyback Program
10/30/2018 6:40:56 AM Allergan Inc. (AGN) Has Raised Its FY18 Revenue Estimate To $15.550 - $15.700 Bln From $15.450 - $15.600 Bln
10/30/2018 6:40:27 AM Allergan Inc. (AGN) Has Raised Its FY18 EPS Estimate To 16.20 - 16.60 From 16.00 - 16.50
10/30/2018 6:32:54 AM Allergan Q3 Non-GAAP Performance Net EPS $4.25 Vs $4.15 Prior Year
10/26/2018 7:34:09 AM Allergan Declares Cash Dividend Of $0.72/Shr; Record Nov 13/Payable Dec 14
10/26/2018 7:32:10 AM Allergan Inc. (AGN) Declares $ 0.72 Dividend for Q4 18, Record Date 11/13/2018
10/19/2018 7:31:59 AM Allergan To Showcase Continued Eye Care Innovation With New Data On Investigational Medicines At AAO Annual Meeting
10/17/2018 7:34:27 AM Allergan Completes Two Positive Safety And Tolerability Studies Of Ubrogepant For Acute Treatment Of Migraine
10/16/2018 9:02:54 AM Allergan : FDA Oks Medicines360's SNDA For LILETTA 52 Mg To Prevent Pregnancy For Up To Five Years
10/5/2018 7:31:40 AM Allergan Initiates Two Global Clinical Research Programs For Brazikumab For Inflammatory Bowel Disease